183 related articles for article (PubMed ID: 34021236)
1. Common DNA methylation dynamics in endometriod adenocarcinoma and glioblastoma suggest universal epigenomic alterations in tumorigenesis.
Karlow JA; Miao B; Xing X; Wang T; Zhang B
Commun Biol; 2021 May; 4(1):607. PubMed ID: 34021236
[TBL] [Abstract][Full Text] [Related]
2. Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis.
Liao X; Siu MK; Chan KY; Wong ES; Ngan HY; Chan QK; Li AS; Khoo US; Cheung AN
Int J Cancer; 2008 Jul; 123(2):296-302. PubMed ID: 18404674
[TBL] [Abstract][Full Text] [Related]
3. Recurrent patterns of DNA methylation in the ZNF154, CASP8, and VHL promoters across a wide spectrum of human solid epithelial tumors and cancer cell lines.
Sánchez-Vega F; Gotea V; Petrykowska HM; Margolin G; Krivak TC; DeLoia JA; Bell DW; Elnitski L
Epigenetics; 2013 Dec; 8(12):1355-72. PubMed ID: 24149212
[TBL] [Abstract][Full Text] [Related]
4. Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene.
Hoivik EA; Kusonmano K; Halle MK; Berg A; Wik E; Werner HM; Petersen K; Oyan AM; Kalland KH; Krakstad C; Trovik J; Widschwendter M; Salvesen HB
Oncotarget; 2014 Feb; 5(4):1052-61. PubMed ID: 24658009
[TBL] [Abstract][Full Text] [Related]
5. Current concepts in the pathology and epigenetics of endometrial carcinoma.
Arafa M; Somja J; Dehan P; Kridelka F; Goffin F; Boniver J; Delvenne P
Pathology; 2010 Dec; 42(7):613-7. PubMed ID: 21080868
[TBL] [Abstract][Full Text] [Related]
6. DNMT3A/3B overexpression might be correlated with poor patient survival, hypermethylation and low expression of ESR1/PGR in endometrioid carcinoma: an analysis of The Cancer Genome Atlas.
He D; Wang X; Zhang Y; Zhao J; Han R; Dong Y
Chin Med J (Engl); 2019 Jan; 132(2):161-170. PubMed ID: 30614867
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogramming.
Suryo Rahmanto Y; Shen W; Shi X; Chen X; Yu Y; Yu ZC; Miyamoto T; Lee MH; Singh V; Asaka R; Shimberg G; Vitolo MI; Martin SS; Wirtz D; Drapkin R; Xuan J; Wang TL; Shih IM
Nat Commun; 2020 Jun; 11(1):2717. PubMed ID: 32483112
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of miR-203 in endometrial carcinomas.
Huang YW; Kuo CT; Chen JH; Goodfellow PJ; Huang TH; Rader JS; Uyar DS
Gynecol Oncol; 2014 May; 133(2):340-5. PubMed ID: 24530564
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation contributes to TIMP3 down-regulation in high stage endometrioid endometrial carcinomas.
Catasus L; Pons C; Muñoz J; Espinosa I; Prat J
Histopathology; 2013 Mar; 62(4):632-41. PubMed ID: 23379820
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk between DNA methylation and histone acetylation triggers GDNF high transcription in glioblastoma cells.
Zhang B; Gu X; Han X; Gao Q; Liu J; Guo T; Gao D
Clin Epigenetics; 2020 Mar; 12(1):47. PubMed ID: 32183903
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide DNA methylation profile of early-onset endometrial cancer: its correlation with genetic aberrations and comparison with late-onset endometrial cancer.
Makabe T; Arai E; Hirano T; Ito N; Fukamachi Y; Takahashi Y; Hirasawa A; Yamagami W; Susumu N; Aoki D; Kanai Y
Carcinogenesis; 2019 Jul; 40(5):611-623. PubMed ID: 30850842
[TBL] [Abstract][Full Text] [Related]
12. ASH2L is involved in promotion of endometrial cancer progression via upregulation of PAX2 transcription.
Zeng K; Wu Y; Wang C; Wang S; Sun H; Zou R; Sun G; Song H; Liu W; Sun N; Wei S; Liu W; Su Y; Zhou T; Zhang Y; Zhao Y
Cancer Sci; 2020 Jun; 111(6):2062-2077. PubMed ID: 32279431
[TBL] [Abstract][Full Text] [Related]
13. Methylation profiles of endometrioid and serous endometrial cancers.
Seeber LM; Zweemer RP; Marchionni L; Massuger LF; Smit VT; van Baal WM; Verheijen RH; van Diest PJ
Endocr Relat Cancer; 2010 Sep; 17(3):663-73. PubMed ID: 20488783
[TBL] [Abstract][Full Text] [Related]
14. High frequency of RASSF1A and RARb2 gene promoter methylation in morphologically normal endometrium adjacent to endometrioid adenocarcinoma.
Arafa M; Kridelka F; Mathias V; Vanbellinghen JF; Renard I; Foidart JM; Boniver J; Delvenne P
Histopathology; 2008 Nov; 53(5):525-32. PubMed ID: 18783461
[TBL] [Abstract][Full Text] [Related]
15. Importance of promoter methylation of GATA4 and TP53 genes in endometrioid carcinoma of endometrium.
Chmelarova M; Kos S; Dvorakova E; Spacek J; Laco J; Ruszova E; Hrochova K; Palicka V
Clin Chem Lab Med; 2014 Aug; 52(8):1229-34. PubMed ID: 24651021
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation in the p16 promoter region in the carcinogenesis of endometrial cancer in Japanese patients.
Yanokura M; Banno K; Susumu N; Kawaguchi M; Kuwabara Y; Tsukazaki K; Aoki D
Anticancer Res; 2006; 26(2A):851-6. PubMed ID: 16619479
[TBL] [Abstract][Full Text] [Related]
17. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
[TBL] [Abstract][Full Text] [Related]
18. RASSF1A methylation and K-ras and B-raf mutations and recurrent endometrial cancer.
Pijnenborg JM; Dam-de Veen GC; Kisters N; Delvoux B; van Engeland M; Herman JG; Groothuis PG
Ann Oncol; 2007 Mar; 18(3):491-7. PubMed ID: 17170014
[TBL] [Abstract][Full Text] [Related]
19. Integrative analysis of DNA methylation suggests down-regulation of oncogenic pathways and reduced somatic mutation rates in survival outliers of glioblastoma.
Hwang T; Mathios D; McDonald KL; Daris I; Park SH; Burger PC; Kim S; Dho YS; Carolyn H; Bettegowda C; Shin JH; Lim M; Park CK
Acta Neuropathol Commun; 2019 Jun; 7(1):88. PubMed ID: 31159876
[TBL] [Abstract][Full Text] [Related]
20. PRMT2 links histone H3R8 asymmetric dimethylation to oncogenic activation and tumorigenesis of glioblastoma.
Dong F; Li Q; Yang C; Huo D; Wang X; Ai C; Kong Y; Sun X; Wang W; Zhou Y; Liu X; Li W; Gao W; Liu W; Kang C; Wu X
Nat Commun; 2018 Oct; 9(1):4552. PubMed ID: 30382083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]